Stocktoria

HERBALIFE LTD. HLF

NYSE · XNYS · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Chart by TradingView
5/9
Piotroski F — financial health
0.63
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials (annual, from 10-K)

FYRevenueNet incomeGross profitFree cash flowEquity
2025$5.0B$228.3M$3.9B$252.9M-$509.4M
2024$5.0B$254.3M$3.9B$163.4M-$801.1M
2023$5.1B$142.2M$3.9B$222.5M-$1.1B
2022$5.2B$321.3M$4.0B$196.1M-$1.3B
2021$5.8B$447.2M$4.6B$308.9M-$1.4B
2020$5.5B$372.6M$4.4B$516.6M-$856.1M

Recent insider activity (Form 4)

InsiderRoleDateActionSharesPrice
L'Helias Sophiedirector2026-06-04Buy1,200$11.31
Hicks TroyChief Operating Officer2026-05-19Sell10,000$12.32
Hicks TroyChief Operating Officer2026-05-18Option exercise17,481$8.31
Hicks TroyChief Operating Officer2026-05-18Option exercise65,789$9.58
Hicks TroyChief Operating Officer2026-05-18Tax withheld58,064$12.59
Hicks TroyChief Operating Officer2026-05-18Tax withheld14,562$12.59
Hicks TroyChief Operating Officer2026-05-18Sell38,377$12.93
Lamberti FrankChief Commercial Officer2026-05-12Sell134,982$13.50

Why these scores methodology →

Piotroski F-score: 5/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 0.63 (distress)

  • Working capital / assets 0.047
  • Retained earnings / assets -0.208
  • EBIT / assets 0.173
  • Equity / liabilities -0.155

Source: SEC EDGAR filings · CIK 0001180262 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.